Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Diabetes Mellitus, Type 2"" wg kryterium: Temat


Tytuł :
Hospitalization and mortality in patients with COVID-19 with or at risk of type 2 diabetes: data from five health systems in Pennsylvania and Maryland.
Autorzy :
Yeh HC; Department of Medicine, Johns Hopkins University, Baltimore, Maryland, USA .
Kraschnewski JL; Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Kong L; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Lehman EB; Department of Public Health Sciences, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Heilbrunn ES; Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Williams P; Cancer and Chronic Disease Bureau, Maryland Department of Health, Baltimore, Maryland, USA.
Poger JM; Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Francis E; Department of Medicine, Penn State College of Medicine, Hershey, Pennsylvania, USA.
Bryce CL; Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Pokaż więcej
Źródło :
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2022 Jun; Vol. 10 (3).
Typ publikacji :
Clinical Study; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19*/complications
COVID-19*/epidemiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Insulins*
Adult ; Hospitalization ; Humans ; Maryland/epidemiology ; Pennsylvania/epidemiology ; Retrospective Studies
Czasopismo naukowe
Tytuł :
Efficacy and safety of the combined metabolic medication, containing inosine, nicotinamide, riboflavin and succinic acid, for the treatment of diabetic neuropathy: a multicenter randomized, double-blind, placebo-controlled parallel group clinical trial (CYLINDER).
Autorzy :
Kharitonova T; Department of Acute Cerebrovascular Pathology and Emergency Neurology, Sankt-Peterburgskij naucno-issledovatel'skij institut skoroj pomosi imeni I I Dzanelidze, Sankt Peterburg, Russian Federation .
Shvarts YG; Department of Faculty Therapy, City Clinical Hospital, Saratov, Russian Federation.
Verbovoy AF; Department of Endocrinilogy, Limited Liability Company 'Center Diabetes', Samara, Russian Federation.
Orlova NS; Endocrinologist, 'Eco-Safety' Medical Center, St Petersburg, Russian Federation.
Puzyreva VP; City Endocrinology Center, City Hospital No 4, Rostov-on-Don, Russian Federation.
Strokov IA; Department of Nervous Diseases and Neurosurgery, Sechenov University, Moskva, Russian Federation.
Pokaż więcej
Źródło :
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2022 Jun; Vol. 10 (3).
Typ publikacji :
Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetic Neuropathies*/drug therapy
Antioxidants/therapeutic use ; Female ; Humans ; Inosine/therapeutic use ; Male ; NAD/therapeutic use ; Niacinamide/adverse effects ; Riboflavin/adverse effects ; Succinic Acid/therapeutic use
Czasopismo naukowe
Tytuł :
Behavioral, psychological, and clinical outcomes of Arabic-speaking people with type 2 diabetes during COVID-19 pandemic.
Autorzy :
Alzubaidi H; College of Pharmacy, University of Sharjah, University City Road, University City, PO Box 27272, Sharjah, United Arab Emirates; Sharjah Institute for Medical Research, University of Sharjah, University City Road - University City, PO Box 27272, Sharjah, United Arab Emirates. Electronic address: .
Hafidh K; Rashid Hospital, Dubai Health Authority UAE, Dubai Medical College, United Arab Emirates. Electronic address: .
Saidawi W; Sharjah Institute for Medical Research, University of Sharjah, University City Road - University City, PO Box 27272, Sharjah, United Arab Emirates. Electronic address: .
Othman AM; College of Pharmacy, University of Sharjah, University City Road, University City, PO Box 27272, Sharjah, United Arab Emirates. Electronic address: .
Khakpour MM; College of Pharmacy, University of Sharjah, University City Road, University City, PO Box 27272, Sharjah, United Arab Emirates. Electronic address: .
Zoghbor MM; Pharmacist, Fakeeh University Hospital, Dubai Silicon Oasis, Dubai, United Arab Emirates. Electronic address: .
Abu-Gharbieh E; Sharjah Institute for Medical Research, University of Sharjah, University City Road - University City, PO Box 27272, Sharjah, United Arab Emirates; Department of Clinical Sciences, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates. Electronic address: .
Alzoubi KH; College of Pharmacy, University of Sharjah, University City Road, University City, PO Box 27272, Sharjah, United Arab Emirates. Electronic address: .
Shaw JE; Clinical and Population Health, Baker Institute, Baker Heart and Diabetes Institute, Level 4, 99 Commercial Road, PO Box 6492, Melbourne, VIC 3004, Australia. Electronic address: .
Pokaż więcej
Źródło :
Primary care diabetes [Prim Care Diabetes] 2022 Jun; Vol. 16 (3), pp. 355-360. Date of Electronic Publication: 2022 Apr 08.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/epidemiology
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/therapy
Cross-Sectional Studies ; Humans ; Middle Aged ; Pandemics ; Self Care
Czasopismo naukowe
Tytuł :
Achieving diabetes treatment targets in people with registered mental illness is similar or improved compared with those without: Analyses of linked observational datasets.
Autorzy :
Nieuwenhuijse EA; Department of Public Health and Primary Care, LUMC-Campus The Hague, Leiden University Medical Centre, The Hague, The Netherlands.
Struijs JN; Department of Public Health and Primary Care, LUMC-Campus The Hague, Leiden University Medical Centre, The Hague, The Netherlands.; National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Sutch SP; Department of Public Health and Primary Care, LUMC-Campus The Hague, Leiden University Medical Centre, The Hague, The Netherlands.; Health Policy and Management, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.
Numans ME; Department of Public Health and Primary Care, LUMC-Campus The Hague, Leiden University Medical Centre, The Hague, The Netherlands.
Vos RC; Department of Public Health and Primary Care, LUMC-Campus The Hague, Leiden University Medical Centre, The Hague, The Netherlands.
Pokaż więcej
Źródło :
Diabetic medicine : a journal of the British Diabetic Association [Diabet Med] 2022 Jun; Vol. 39 (6), pp. e14835. Date of Electronic Publication: 2022 Apr 01.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Mental Disorders*/complications
Mental Disorders*/epidemiology
Blood Pressure/physiology ; Cholesterol, LDL ; Glycated Hemoglobin A/analysis ; Humans ; Male
Czasopismo naukowe
Tytuł :
Shouldn't Preventing Type 2 Diabetes Also Prevent Its Long-Term Consequences?
Autorzy :
Gerstein HC; Population Health Research Institute, McMaster University and Hamilton Health Sciences, Canada.
Pokaż więcej
Źródło :
Circulation [Circulation] 2022 May 31; Vol. 145 (22), pp. 1642-1644. Date of Electronic Publication: 2022 May 31.
Typ publikacji :
Editorial
MeSH Terms :
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/prevention & control
Humans
Opinia redakcyjna
Tytuł :
Effects of Long-term Metformin and Lifestyle Interventions on Cardiovascular Events in the Diabetes Prevention Program and Its Outcome Study.
Autorzy :
Goldberg RB; University of Miami Miller School of Medicine, FL (R.B.G.).
Orchard TJ; University of Pittsburgh Graduate School of Public Health, PA (T.J.O.).
Crandall JP; Albert Einstein College of Medicine, Bronx, NY (J.P.C.).
Boyko EJ; VA Puget Sound Health Care System, Seattle, WA (E.J.B.).
Budoff M; Los Angeles Biomedical Research Institute, Torrance, CA (M.B.).
Dabelea D; University of Colorado Anschutz Medical Campus, Aurora (D.D.).
Gadde KM; Pennington Biomedical Research Center, Baton Rouge, LA (K.M.G.).
Knowler WC; National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ (W.C.K.).
Lee CG; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD (C.G.L.).
Nathan DM; Massachusetts General Hospital, Harvard Medical School, Boston (D.M.N.).
Watson K; David Geffen School of Medicine at UCLA, Los Angeles, CA (K.W.).
Temprosa M; Biostatistics Center and Milken Institute School of Public Health, George Washington University, Rockville, MD (M.T.).
Pokaż więcej
Corporate Authors :
Diabetes Prevention Program Research Group*
Źródło :
Circulation [Circulation] 2022 May 31; Vol. 145 (22), pp. 1632-1641. Date of Electronic Publication: 2022 May 23.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Metformin*/therapeutic use
Myocardial Infarction*/drug therapy
Humans ; Hypoglycemic Agents/therapeutic use ; Life Style ; Outcome Assessment, Health Care
Czasopismo naukowe
Tytuł :
Efficacy and Safety of Dapagliflozin in Type 2 Diabetes According to Baseline Blood Pressure: Observations From DECLARE-TIMI 58 Trial.
Autorzy :
Furtado RHM; Academic Research Organization, Hospital Israelita Albert Einstein, Sao Paulo, Brazil (R.H.M.F.).; Instituto do Coracao (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo, Brazil (R.H.M.F., J.C.N.).; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.).
Raz I; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.).
Goodrich EL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.).
Murphy SA; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.).
Bhatt DL; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.).
Leiter LA; Li Ka Shing Knowledge Institute, St. Michael's Hospital, University of Toronto, ON, Canada (L.A.L.).
McGuire DK; Division of Cardiology, University of Texas Southwestern Medical Center and Parkland Health and Hospital System, Dallas (D.K.M.).
Wilding JPH; Department of Cardiovascular and Metabolic Medicine, University of Liverpool, United Kingdom (J.P.H.W.).
Aylward P; South Australian Health and Medical Research Institute, Flinders University and Medical Centre, Adelaide (P.A.).
Dalby AJ; Life Fourways Hospital, Randburg, Republic of South Africa (A.J.D.).
Dellborg M; Sahlgrenska Academy, University of Gothenburg, Sweden (M.D.).
Dimulescu D; Carol Davila University of Medicine and Pharmacy, Bucharest, Romania (D.D.).
Nicolau JC; Instituto do Coracao (InCor), Hospital das Clinicas da Faculdade de Medicina, Universidade de Sao Paulo, Brazil (R.H.M.F., J.C.N.).
Oude Ophuis AJM; Department of Cardiology, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands (A.J.M.O.O.).
Cahn A; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.).
Mosenzon O; Diabetes Unit, Department of Endocrinology and Metabolism, Hadassah Medical Center, Hebrew University of Jerusalem, The Faculty of Medicine, Israel (I.R.A.C., O.M.).
Gause-Nilsson I; BioPharmaceuticals R&D, AstraZeneca Gothenburg, Mölndal, Sweden (I.G.-N., A.M.L.).
Langkilde AM; BioPharmaceuticals R&D, AstraZeneca Gothenburg, Mölndal, Sweden (I.G.-N., A.M.L.).
Sabatine MS; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.).
Wiviott SD; TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women's Hospital Heart and Harvard Medical School, Boston, MA (R.H.M.F., E.L.G., S.A.M., D.L.B., M.S.S., S.D.W.).
Pokaż więcej
Źródło :
Circulation [Circulation] 2022 May 24; Vol. 145 (21), pp. 1581-1591. Date of Electronic Publication: 2022 May 05.
Typ publikacji :
Journal Article; Randomized Controlled Trial
MeSH Terms :
Acute Kidney Injury*/chemically induced
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/drug therapy
Heart Failure*
Myocardial Infarction*/drug therapy
Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use
Aged ; Benzhydryl Compounds/adverse effects ; Blood Pressure ; Female ; Glucosides ; Humans ; Male ; Middle Aged
Czasopismo naukowe
Tytuł :
Management of type 2 diabetes in young adults aged 18-30 years: ADS/ADEA/APEG consensus statement.
Autorzy :
Wong J; Sydney Medical School and Charles Perkins Centre, University of Sydney, Sydney, NSW.; Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW.
Ross GP; Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW.; University of Sydney, Sydney, NSW.
Zoungas S; Monash University, Melbourne, VIC.
Craig ME; University of Sydney, Sydney, NSW.; Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, NSW.; UNSW Sydney, Sydney, NSW.
Davis EA; Perth Children's Hospital, Perth, WA.; Telethon Kids Institute, Perth, WA.
Donaghue KC; University of Sydney, Sydney, NSW.; Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, NSW.
Maple-Brown LJ; Menzies School of Health Research, Charles Darwin University, Darwin, NT.; Royal Darwin Hospital, Darwin, NT.
McGill MJ; Diabetes Centre, Royal Prince Alfred Hospital, Sydney, NSW.; University of Sydney, Sydney, NSW.
Shaw JE; Baker Heart and Diabetes Institute, Melbourne, VIC.
Speight J; Deakin University, Geelong, VIC.; Australian Centre for Behavioural Research in Diabetes, Diabetes Victoria, Melbourne, VIC.
Wischer N; National Association of Diabetes Centres, Sydney, NSW.; Monash University, Melbourne, VIC.
Stranks S; Flinders University, Adelaide, SA.; Southern Adelaide Diabetes and Endocrine Services, Flinders Medical Centre, Adelaide, SA.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2022 May 02; Vol. 216 (8), pp. 422-429. Date of Electronic Publication: 2022 Apr 17.
Typ publikacji :
Journal Article
MeSH Terms :
Cardiovascular Diseases*/prevention & control
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/therapy
Adolescent ; Adult ; Aged ; Australia/epidemiology ; Child ; Female ; Glucose ; Humans ; Obesity ; Pregnancy ; Young Adult
Czasopismo naukowe
Tytuł :
Dapagliflozin protects neural and vascular dysfunction of the retina in diabetes.
Autorzy :
Luo Q; Department of Ophthalmology, Indiana University, Indianapolis, Indiana, USA.
Leley SP; School of Medicine, Indiana University, Indianapolis, Indiana, USA.
Bello E; Department of Ophthalmology, Indiana University, Indianapolis, Indiana, USA.
Dhami H; Department of Ophthalmology, Indiana University, Indianapolis, Indiana, USA.
Mathew D; Department of Ophthalmology, Indiana University, Indianapolis, Indiana, USA.
Bhatwadekar AD; Department of Ophthalmology, Indiana University, Indianapolis, Indiana, USA .
Pokaż więcej
Źródło :
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2022 May; Vol. 10 (3).
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Diabetic Retinopathy*/drug therapy
Diabetic Retinopathy*/etiology
Diabetic Retinopathy*/prevention & control
Animals ; Benzhydryl Compounds ; Blood Glucose ; Endothelial Cells ; Glucosides ; Mice ; Retina
Czasopismo naukowe
Tytuł :
Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66).
Autorzy :
Yokoyama H; Jiyugaoka Medical Clinic Internal Medicine, Obihiro, Japan .
Araki SI; Department of Internal Medicine, Division of Nephrology, Wakayama Medical University, Wakayama, Japan.
Yamazaki K; Kawai Clinic, Tsukuba, Japan.
Kawai K; Kawai Clinic, Tsukuba, Japan.
Shirabe SI; HEC Science Clinic, Yokohama, Japan.
Oishi M; Oishi Clinic, Kyoto, Japan.
Kanatsuka A; Chiba Central Medical Center, Chiba, Japan.
Yagi N; Yagi Medical Clinic, Okinawa, Japan.
Kabata D; Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Shintani A; Department of Medical Statistics, Osaka City University Graduate School of Medicine, Osaka, Japan.
Maegawa H; Department of Medicine, Shiga University of Medical Science, Otsu, Japan.
Pokaż więcej
Corporate Authors :
JDDM study group
Źródło :
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2022 May; Vol. 10 (3).
Typ publikacji :
Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Insulin*/therapeutic use
Cross-Sectional Studies ; Glycated Hemoglobin A/analysis ; Glycemic Control ; Humans ; Hypoglycemic Agents/therapeutic use ; Insulin, Regular, Human ; Japan/epidemiology
Czasopismo naukowe
Tytuł :
Uptake and impact of the English National Health Service digital diabetes prevention programme: observational study.
Autorzy :
Ross JAD; Research Department of Primary Care and Population Health, University College London, London, UK .
Barron E; NHS England and Improvement, London, UK.
McGough B; NHS England and Improvement, London, UK.
Valabhji J; NHS England and Improvement, London, UK.; Department of Diabetes and Endocrinology, Imperial College Healthcare NHS Trust, London, UK.
Daff K; RSM UK Consulting LLP, Cambridge, UK.
Irwin J; RSM UK Consulting LLP, Cambridge, UK.
Henley WE; Health Statistics Group, Institute of Health Research, University of Exeter, Exeter, UK.
Murray E; Research Department of Primary Care and Population Health, University College London, London, UK.
Pokaż więcej
Źródło :
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2022 May; Vol. 10 (3).
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/prevention & control
Hyperglycemia*
Adult ; Glycated Hemoglobin A ; Humans ; Prospective Studies ; State Medicine
Czasopismo naukowe
Tytuł :
Effectiveness of cognitive behavioral therapy-based interventions on psychological symptoms in adults with type 2 diabetes mellitus: An update review of randomized controlled trials.
Autorzy :
Vlachou E; Department of Nursing, University of West Attica, Athens, Greece. Electronic address: .
Ntikoudi A; Department of Nursing, University of West Attica, Athens, Greece.
Owens DA; Medical School, National and Kapodistrian University of Athens, Greece.
Nikolakopoulou M; Medical School, National and Kapodistrian University of Athens, Greece.
Chalimourdas T; 1st Department of Psychiatry, Eginition Hospital, Medical School-National and Kapodistrian University of Athens, Greece.
Cauli O; Frailty and Cognitive Impairment Group (FROG), University of Valencia, 46010 Valencia, Spain; Department of Nursing, University of Valencia, 46010 Valencia, Spain. Electronic address: .
Pokaż więcej
Źródło :
Journal of diabetes and its complications [J Diabetes Complications] 2022 May; Vol. 36 (5), pp. 108185. Date of Electronic Publication: 2022 Mar 26.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Cognitive Behavioral Therapy*/methods
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/psychology
Diabetes Mellitus, Type 2*/therapy
Adult ; Anxiety/psychology ; Depression/therapy ; Humans ; Psychotherapy/methods ; Randomized Controlled Trials as Topic
Czasopismo naukowe
Tytuł :
Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients.
Autorzy :
Mahjoob G; Department of Clinical Biochemistry, Sarab Faculty of Medical Sciences., Sarab, Iran.; Department of Clinical Biochemistry, Tarbiat Modares University, Tehran, Iran.
Ahmadi Y; Department of Medical Laboratory Sciences, College of Science, Komar University of Science and Technology, Sulaimani, Iraq.
Fatima Rajani H; Department of medical biotechnology, School of advanced sciences in medicine, Tehran University of medical sciences, Tehran, Iran.
Khanbabaei N; Department of Clinical Biochemistry, Sarab Faculty of Medical Sciences., Sarab, Iran.; Department of Clinical Biochemistry, Tarbiat Modares University, Tehran, Iran.
Abolhasani S; Department of Clinical Biochemistry, Sarab Faculty of Medical Sciences., Sarab, Iran.; Department of Clinical Biochemistry, Tarbiat Modares University, Tehran, Iran.
Pokaż więcej
Źródło :
Journal of clinical laboratory analysis [J Clin Lab Anal] 2022 May; Vol. 36 (5), pp. e24380. Date of Electronic Publication: 2022 Mar 29.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Circulating MicroRNA*/genetics
Coronary Artery Disease*/diagnosis
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/genetics
MicroRNAs*/genetics
Biomarkers ; Humans
Czasopismo naukowe
Tytuł :
Benefits of GLP-1 (Glucagon-Like Peptide 1) Receptor Agonists for Stroke Reduction in Type 2 Diabetes: A Call to Action for Neurologists.
Autorzy :
Goldenberg RM; LMC Diabetes & Endocrinology, Canada (R.M.G.).
Cheng AYY; Trillium Health Partners, St Michael's Hospital, University of Toronto, Canada (A.Y.Y.C.).
Fitzpatrick T; Mackenzie Health, Canada (T.F.).
Gilbert JD; Sunnybrook Health Sciences Centre, University of Toronto, Canada (J.D.G.).
Verma S; St Michael's Hospital, University of Toronto, Canada (S.V.).
Hopyan JJ; Sunnybrook Health Sciences Centre, University of Toronto, Canada (J.J.H.).
Pokaż więcej
Źródło :
Stroke [Stroke] 2022 May; Vol. 53 (5), pp. 1813-1822. Date of Electronic Publication: 2022 Mar 09.
Typ publikacji :
Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/drug therapy
Stroke*/drug therapy
Glucagon-Like Peptide 1 ; Glucagon-Like Peptide-1 Receptor/agonists ; Humans ; Neurologists
Czasopismo naukowe
Tytuł :
Circulating miRNA as potential biomarkers for diabetes mellitus type 2: should we focus on searching for sex differences?
Autorzy :
Kraczkowska W; Department of Biochemistry and Molecular Biology, Poznań University of Medical Science, 6 Święcickiego Street, 60-781, Poznan, Poland.
Stachowiak L; Department of Biochemistry and Molecular Biology, Poznań University of Medical Science, 6 Święcickiego Street, 60-781, Poznan, Poland.
Pławski A; Institute of Human Genetics, Polish Academy of Sciences, 60-479, Poznan, Poland.
Jagodziński PP; Department of Biochemistry and Molecular Biology, Poznań University of Medical Science, 6 Święcickiego Street, 60-781, Poznan, Poland. .
Pokaż więcej
Źródło :
Journal of applied genetics [J Appl Genet] 2022 May; Vol. 63 (2), pp. 293-303. Date of Electronic Publication: 2022 Jan 05.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Diabetes Mellitus, Type 2*/diagnosis
Diabetes Mellitus, Type 2*/genetics
MicroRNAs*/genetics
Biomarkers ; Female ; Humans ; Male ; Sex Characteristics
Czasopismo naukowe
Tytuł :
Comparison of Prevailing Insulin Regimens at Different Time Periods in Hospitalized Patients: A Real-World Experience from a Tertiary Hospital.
Autorzy :
Moon SJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.
Choe HJ; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Kwak SH; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Jung HS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Park KS; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Cho YM; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.; Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea.
Pokaż więcej
Źródło :
Diabetes & metabolism journal [Diabetes Metab J] 2022 May; Vol. 46 (3), pp. 439-450. Date of Electronic Publication: 2021 Oct 20.
Typ publikacji :
Journal Article; Observational Study; Research Support, Non-U.S. Gov't
MeSH Terms :
Diabetes Mellitus, Type 2*/drug therapy
Diabetes Mellitus, Type 2*/epidemiology
Hypoglycemia*/chemically induced
Hypoglycemia*/epidemiology
Biphasic Insulins/therapeutic use ; Blood Glucose ; Humans ; Hypoglycemic Agents/therapeutic use ; Insulin/therapeutic use ; Tertiary Care Centers
Czasopismo naukowe
Tytuł :
Independent risk factors of COVID-19 pneumonia in vaccinated Mexican adults.
Autorzy :
Murillo-Zamora E; Departamento de Epidemiología, Unidad de Medicina Familiar No. 19, Instituto Mexicano del Seguro Social, Av. Javier Mina 301, Col. Centro, C.P. 28000, Colima, Colima, México; Facultad de Medicina, Universidad de Colima, Av. Universidad 333, Col. Las Víboras, C.P. 28040, Colima, Colima, México. Electronic address: .
Sánchez-Piña RA; Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, MA, 02115, USA.
Trujillo X; Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Av. 25 de julio 965, Col. Villas San Sebastián, C.P. 28045 Colima, México.
Huerta M; Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Av. 25 de julio 965, Col. Villas San Sebastián, C.P. 28045 Colima, México.
Ríos-Silva M; Universidad de Colima - CONACyT, Centro Universitario de Investigaciones Biomédicas, Av. 25 de julio 965, Col. Villas San Sebastián, C.P. 28045 Colima, México.
Mendoza-Cano O; Facultad de Ingeniería Civil, Universidad de Colima, km. 9 carretera Colima-Coquimatlán, Coquimatlán, C.P. 28400, Colima, México. Electronic address: .
Pokaż więcej
Źródło :
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases [Int J Infect Dis] 2022 May; Vol. 118, pp. 244-246. Date of Electronic Publication: 2022 Feb 12.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*/epidemiology
COVID-19*/prevention & control
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Pneumonia*
Adult ; COVID-19 Vaccines ; Cohort Studies ; Humans ; Mexico/epidemiology ; Risk Factors
Czasopismo naukowe
Tytuł :
Sex Differences of Visceral Fat Area and Visceral-to-Subcutaneous Fat Ratio for the Risk of Incident Type 2 Diabetes Mellitus.
Autorzy :
Kim EH; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim HK; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lee MJ; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Bae SJ; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Choe J; Health Screening and Promotion Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Jung CH; Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.; Asan Diabetes Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Kim CH; Division of Endocrinology and Metabolism, Department of Internal Medicine, Soonchunhyang University Bucheon Hospital, Soonchunhyang University College of Medicine, Bucheon, Korea.
Park JY; Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.; Asan Diabetes Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Lee WJ; Division of Endocrinology and Metabolism, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul, Korea.; Asan Diabetes Center, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Pokaż więcej
Źródło :
Diabetes & metabolism journal [Diabetes Metab J] 2022 May; Vol. 46 (3), pp. 486-498. Date of Electronic Publication: 2021 Nov 18.
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Intra-Abdominal Fat*/diagnostic imaging
Adult ; Aged ; Female ; Humans ; Male ; Middle Aged ; Obesity, Abdominal/complications ; Sex Characteristics ; Subcutaneous Fat/diagnostic imaging
Czasopismo naukowe
Tytuł :
[Incidence and risk factors of ischemic stroke in patients with type 2 diabetes among urban workers in Beijing, China].
Autorzy :
Wu JH; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Wu YQ; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Wu Y; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Wang ZJ; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Wu T; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Qin XY; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Wang MY; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Wang XW; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Wang JT; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Hu YH; Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China.
Pokaż więcej
Źródło :
Beijing da xue xue bao. Yi xue ban = Journal of Peking University. Health sciences [Beijing Da Xue Xue Bao Yi Xue Ban] 2022 Apr 18; Vol. 54 (2), pp. 249-254.
Typ publikacji :
Journal Article
MeSH Terms :
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Ischemic Stroke*
Stroke*/epidemiology
Stroke*/etiology
Adult ; Aged ; Aged, 80 and over ; Beijing/epidemiology ; Female ; Humans ; Incidence ; Male ; Middle Aged ; Prospective Studies ; Risk Factors
Czasopismo naukowe
Tytuł :
Women with type 2 diabetes and coronary artery disease have a higher risk of heart failure than men, with a significant gender interaction between heart failure risk and risk factor management: a retrospective registry study.
Autorzy :
Fujita Y; Department of Clinical Research and Management, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.; Department of Clinical Pharmacology and Therapeutics, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Morimoto T; Department of Clinical Epidemiology, Hyogo College of Medicine, Hyogo, Japan.
Tokushige A; Department of Clinical Pharmacology and Therapeutics, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Ikeda M; Department of Medical Informatics, Kagawa University Hospital, Kagawa, Japan.
Shimabukuro M; Department of Diabetes, Endocrinology and Metabolism, Fukushima Medical University, Fukushima, Japan.
Node K; Department of Cardiology, Saga University School of Medicine, Saga, Japan.
Ueda S; Department of Clinical Research and Management, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan .; Department of Clinical Pharmacology and Therapeutics, Graduate School of Medicine, University of the Ryukyus, Okinawa, Japan.
Pokaż więcej
Źródło :
BMJ open diabetes research & care [BMJ Open Diabetes Res Care] 2022 Apr; Vol. 10 (2).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Coronary Artery Disease*/complications
Coronary Artery Disease*/etiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Heart Failure*/complications
Heart Failure*/etiology
Aged ; Cholesterol, LDL ; Female ; Humans ; Male ; Registries ; Retrospective Studies ; Risk Factors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies